DEVELOPMENT OF A NOVEL LIVE ATTENUATED AFRICAN SWINE FEVER VACCINE BASED IN THE DELETION OF GENE I177L
老挝专利「DEVELOPMENT OF A NOVEL LIVE ATTENUATED AFRICAN SWINE FEVER VACCINE BASED IN THE DELETION OF GENE I177L」是 DIP 公开可查的知识产权档案，由 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE 于 2020-03-13 提交申请，当前状态为等待形式审查。关键编号与类型标注为 申请号 P/830 / DIP 编号 LAP830 / 主管局代码 LA / 保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2026-02-27。技术或外观分类记载为 A61K 31/10、A61K 31/4178、A61K 47/08、A61K 47/10、A61K 47/12、A61K 47/14、A61K 47/22、A61K 47/32。发明人 / 设计人包括 BORCA, Manuel V.、GLADUE, Douglas P.。代理机构 / 代理人记载为 Lao Trademark Agency。公开摘要提示：Provided herein are details on the construction of a recombinant African Swine Fever Virus (ASFV) live attenuated vaccine for prevention of…。
This Laos patent “DEVELOPMENT OF A NOVEL LIVE ATTENUATED AFRICAN SWINE FEVER VACCINE BASED IN THE DELETION OF GENE I177L” is a public DIP intellectual-property record, filed by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE on 2020-03-13; current status: Awaiting formal examination. Identifiers include application No. P/830; DIP id LAP830; protection kind Patent - PCT National Phase. Key dates: publication 2026-02-27. Classification: A61K 31/10、A61K 31/4178、A61K 47/08、A61K 47/10、A61K 47/12、A61K 47/14、A61K 47/22、A61K 47/32. Inventor(s)/designer(s): BORCA, Manuel V., GLADUE, Douglas P.. Abstract hint: Provided herein are details on the construction of a recombinant African Swine Fever Virus (ASFV) live attenuated vaccine for prevention of…. Use LaoBiz to hop between this IP record, related filings by the same applicant, and the matched company profile when present.
ໜ້ານີ້ສະຫຼຸບ ສິດທິບັດ «DEVELOPMENT OF A NOVEL LIVE ATTENUATED AFRICAN SWINE FEVER VACCINE BASED IN THE DELETION OF GENE I177L» ຈາກຂໍ້ມູນຈົດທະບຽນເປີດ, ຍື່ນໂດຍ THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE ໃນວັນທີ 2020-03-13; ສະຖານະ ລໍຖ້າກວດຮູບແບບ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/830; ລະຫັດ DIP LAP830; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2026-02-27. ປະເພດ/ຫ້ອງ: A61K 31/10、A61K 31/4178、A61K 47/08、A61K 47/10、A61K 47/12、A61K 47/14、A61K 47/22、A61K 47/32. ນັກປະດິດ/ນັກອອກແບບ: BORCA, Manuel V., GLADUE, Douglas P.. ສະຫຼຸບ: Provided herein are details on the construction of a recombinant African Swine Fever Virus (ASFV) live attenuated vaccine for prevention of…. ຂໍ້ຄວາມນີ້ເນັ້ນຕົວເລກ, ວັນທີ, ປະເພດ ແລະ ຜູ້ຍື່ນ ເພື່ອຫຼຸດຄວາມຄ້າຍຄືນລະຫວ່າງໜ້າ IP; ກວດຂໍ້ມູນທາງການກ່ອນຕັດສິນໃຈ.
P/830
图样
基础信息
- 类型
- 专利
- 申请号
P/830- 状态
- 等待形式审查
- 申请人
- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE
- 代理机构
- Lao Trademark Agency
- 申请日期
- 2020-03-13
- 公开/公告日
- 2026-02-27
- 国际分类
- A61K 31/10 · A61K 31/4178 · A61K 47/08 · A61K 47/10 · A61K 47/12 · A61K 47/14 · A61K 47/22 · A61K 47/32 · A61K 47/34
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
Provided herein are details on the construction of a recombinant African Swine Fever Virus (ASFV) live attenuated vaccine for prevention of ASF caused by various strains of ASFV, such as the highly virulent Georgia 2007 isolate ("ASFV-G"). An exemplary vaccine comprises the ASFV-GΔI177l modified virus, a recombinant ASFV-G modified by deleting a portion of the I177L ORF rendering the I177L gene nonfunctional.
Provided herein are details on the construction of a recombinant African Swine Fever Virus (ASFV) live attenuated vaccine for prevention of ASF caused by various strains of ASFV, such as the highly virulent Georgia 2007 isolate ("ASFV-G"). An exemplary vaccine comprises the ASFV-GΔI177l modified virus, a recombinant ASFV-G modified by deleting a portion of the I177L ORF rendering the I177L gene nonfunctional.